<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9751">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05691062</url>
  </required_header>
  <id_info>
    <org_study_id>1944564</org_study_id>
    <nct_id>NCT05691062</nct_id>
  </id_info>
  <brief_title>Titanium vs. PEEK Fusion Devices in 1 Level TLIF</brief_title>
  <acronym>TLIF</acronym>
  <official_title>A Prospective, Randomized Comparison of Titanium vs. PEEK Fusion Devices in 1 Level TLIF</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Twin Cities Spine Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Twin Cities Spine Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate and follow the clinical and radiographic outcomes&#xD;
      of patients undergoing 1 level TLIF randomized to either a titanium or a PEEK spacer to 24&#xD;
      months after surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Transforaminal lumbar interbody fusion (TLIF) remains a common surgical technique for the&#xD;
      management of lumbar spondylosis requiring decompression and fusion. The choice of interbody&#xD;
      spacer remains dependent on surgeon preference with a variety of options available for use.&#xD;
      Two of the most commonly used interbody spacers are made of polyetheretherketone (PEEK) and&#xD;
      titanium.1 While both spacers have produced reliable rates of fusion with good clinical&#xD;
      outcomes, debate remains as to which interbody spacer is superior. Proponents of PEEK argue&#xD;
      that it is radiolucent and has an elastic modulus similar to bone thus decreasing rates of&#xD;
      subsidence. However, PEEK is a hydrophobic material that does not integrate with bone.&#xD;
      Titanium on the other hand demonstrates osseointegration and may lead to increased rates of&#xD;
      fusion.While there are retrospective studies available comparing the two materials, the&#xD;
      studies are small and there is a paucity of prospective data comparing the radiographic and&#xD;
      clinical outcomes of these spacers. Given the frequency with which these spacers are used, it&#xD;
      is important to determine which spacer produces better clinical and radiographic outcomes for&#xD;
      patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2023</start_date>
  <completion_date type="Anticipated">January 11, 2028</completion_date>
  <primary_completion_date type="Anticipated">January 11, 2027</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Prospective randomized clinical trial with two cohorts.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Subjects will be blinded to fusion device.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Fusion Status of 1 level Lumbar TLIF</measure>
    <time_frame>12 months Post-Op</time_frame>
    <description>Assess fusion status of 1 level Lumbar TLIF by reviewing patient CT Scan completed for study purposes.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Revision Surgeries</measure>
    <time_frame>Up to 24 months Post-op</time_frame>
    <description>Monitor and Record Complications and Revision Surgeries</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient Reported Outcome Measures</measure>
    <time_frame>Preoperative time frame up to 24 months Post-op</time_frame>
    <description>Data collected from patient self reported outcome tools</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Spine Fusion</condition>
  <condition>Lumbar Spondylolisthesis</condition>
  <condition>Lumbar Stenosis</condition>
  <arm_group>
    <arm_group_label>PEEK</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Medtronic Capstone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Titanium</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Medtronic Adaptix</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Titanium Fusion Device</intervention_name>
    <description>Titanium fusion device will be utilized for one-level lumbar fusion.</description>
    <arm_group_label>Titanium</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PEEK Fusion Device</intervention_name>
    <description>PEEK fusion device will be utilized for one-level lumbar fusion.</description>
    <arm_group_label>PEEK</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria&#xD;
&#xD;
          1. Patients undergoing 1 level TLIF for the treatment of lumbar stenosis and&#xD;
             spondylolisthesis who have failed at least 6 weeks of non-operative treatment.&#xD;
&#xD;
          2. Patients between 18-70 years of age at the time of surgery.&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          1. Patients under 18 or over 70 years of age at the time of surgery.&#xD;
&#xD;
          2. Patients undergoing more than 1 level of surgery.&#xD;
&#xD;
          3. Patients who have had prior lumbar fusion.&#xD;
&#xD;
          4. Patients requiring surgery for the management of infection, tumor, or trauma.&#xD;
&#xD;
          5. Patients who are pregnant.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>John M Dawson, PhD</last_name>
    <phone>612-775-6200</phone>
    <email>jmdawson@tcspine.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Berit A Swanberg, BA</last_name>
    <phone>612-775-6200</phone>
    <phone_ext>6182</phone_ext>
    <email>baswanberg@tcspine.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Twin Cities Spine Center</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55404</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Rickert M, Fleege C, Tarhan T, Schreiner S, Makowski MR, Rauschmann M, Arabmotlagh M. Transforaminal lumbar interbody fusion using polyetheretherketone oblique cages with and without a titanium coating: a randomised clinical pilot study. Bone Joint J. 2017 Oct;99-B(10):1366-1372. doi: 10.1302/0301-620X.99B10.BJJ-2016-1292.R2.</citation>
    <PMID>28963159</PMID>
  </reference>
  <reference>
    <citation>Hasegawa T, Ushirozako H, Shigeto E, Ohba T, Oba H, Mukaiyama K, Shimizu S, Yamato Y, Ide K, Shibata Y, Ojima T, Takahashi J, Haro H, Matsuyama Y. The Titanium-coated PEEK Cage Maintains Better Bone Fusion With the Endplate Than the PEEK Cage 6 Months After PLIF Surgery: A Multicenter, Prospective, Randomized Study. Spine (Phila Pa 1976). 2020 Aug 1;45(15):E892-E902. doi: 10.1097/BRS.0000000000003464.</citation>
    <PMID>32675599</PMID>
  </reference>
  <reference>
    <citation>Villavicencio AT, Nelson EL, Rajpal S, Beasley K, Burneikiene S. Prospective, randomized, double-blinded clinical trial comparing PEEK and allograft spacers in patients undergoing transforaminal lumbar interbody fusion surgeries. Spine J. 2022 Jan;22(1):84-94. doi: 10.1016/j.spinee.2021.06.005. Epub 2021 Jun 8.</citation>
    <PMID>34116214</PMID>
  </reference>
  <reference>
    <citation>Seaman S, Kerezoudis P, Bydon M, Torner JC, Hitchon PW. Titanium vs. polyetheretherketone (PEEK) interbody fusion: Meta-analysis and review of the literature. J Clin Neurosci. 2017 Oct;44:23-29. doi: 10.1016/j.jocn.2017.06.062. Epub 2017 Jul 21.</citation>
    <PMID>28736113</PMID>
  </reference>
  <reference>
    <citation>Cuzzocrea F, Ivone A, Jannelli E, Fioruzzi A, Ferranti E, Vanelli R, Benazzo F. PEEK versus metal cages in posterior lumbar interbody fusion: a clinical and radiological comparative study. Musculoskelet Surg. 2019 Dec;103(3):237-241. doi: 10.1007/s12306-018-0580-6. Epub 2018 Dec 10.</citation>
    <PMID>30536223</PMID>
  </reference>
  <reference>
    <citation>Nemoto O, Asazuma T, Yato Y, Imabayashi H, Yasuoka H, Fujikawa A. Comparison of fusion rates following transforaminal lumbar interbody fusion using polyetheretherketone cages or titanium cages with transpedicular instrumentation. Eur Spine J. 2014 Oct;23(10):2150-5. doi: 10.1007/s00586-014-3466-9. Epub 2014 Jul 12.</citation>
    <PMID>25015180</PMID>
  </reference>
  <verification_date>April 2023</verification_date>
  <study_first_submitted>January 9, 2023</study_first_submitted>
  <study_first_submitted_qc>January 18, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">January 19, 2023</study_first_posted>
  <last_update_submitted>April 10, 2023</last_update_submitted>
  <last_update_submitted_qc>April 10, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Twin Cities Spine Center</investigator_affiliation>
    <investigator_full_name>Bayard Carlson</investigator_full_name>
    <investigator_title>Staff Surgeon</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spondylolisthesis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

